Nanjing Leads Biolabs Co., Ltd. (HKG:9887)
Hong Kong · Delayed Price · Currency is HKD 54.00
+0.40 (0.75%)
Jun 18, 2026, 4:08 PM HKT
Nanjing Leads Biolabs Market Cap
Nanjing Leads Biolabs has a market cap or net worth of 10.66 billion as of June 18, 2026.
Market Cap
10.66B
Enterprise Value
9.25B
Revenue
197.25M
Ranking
n/a
PE Ratio
n/a
Stock Price
54.00
Market Cap Chart
Since July 25, 2025, Nanjing Leads Biolabs's market cap has decreased from 12.97B to 10.66B, a decrease of -17.83%. That is a compound annual growth rate of -19.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 10.66B | 5.10% |
| Dec 31, 2025 | 10.14B | -21.82% |
| Jul 25, 2025 | 12.97B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zai Lab | 15.61B |
| TenNor Therapeutics (Suzhou) | 13.15B |
| TransThera Sciences (Nanjing) | 12.90B |
| Ascentage Pharma Group International | 12.18B |
| GenFleet Therapeutics (Shanghai) | 10.63B |
| LongBio Pharma (Suzhou) | 10.59B |
| Ascletis Pharma | 9.93B |
| Everest Medicines | 9.54B |